Announcements Trials

Browse Landscape

Status

No longer available 1

Sponsor Class

Study Type

Interventional 217 Observational 21 Expanded_access 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 7 Sarcoma 3 Pancreatic Neoplasms 3 Osteosarcoma 3 Non-Muscle Invasive Bladder Neoplasms 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Melanoma 2 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neurofibrosarcoma 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1 Neuroblastoma 1 Myelodysplastic Syndromes 1 Meningioma 1 Mastocytosis, Systemic 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, Mast-Cell 1 Leukemia 1 Insulinoma 1

Interventions

gallium maltolate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Glioblastoma × 90 days × Clear all

NCT06404034 2026-03-04

Expanded Access to Gallium Maltolate (GaM)

Imaging Biometrics, LLC

No longer available

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡